The global Monkeypox Virus Monoclonal Antibody market size is predicted to grow from US$ 1459 million in 2025 to US$ 2520 million in 2031; it is expected to grow at a CAGR of 9.5% from 2025 to 2031.

Monkeypox virus monoclonal antibodies are highly homogeneous antibodies produced by a single B cell clone and target only a specific antigenic epitope of monkeypox virus.

United States market for Monkeypox Virus Monoclonal Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Monkeypox Virus Monoclonal Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Monkeypox Virus Monoclonal Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Monkeypox Virus Monoclonal Antibody players cover ProteoGenix, ACROBiosystems, Creative Diagnostics, Novus Biologicals, LLC, Merck Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

Infinity Market Research newest research report, the ?Monkeypox Virus Monoclonal Antibody Industry Forecast? looks at past sales and reviews total world Monkeypox Virus Monoclonal Antibody sales in 2024, providing a comprehensive analysis by region and market sector of projected Monkeypox Virus Monoclonal Antibody sales for 2025 through 2031. With Monkeypox Virus Monoclonal Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monkeypox Virus Monoclonal Antibody industry.

This Insight Report provides a comprehensive analysis of the global Monkeypox Virus Monoclonal Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Monkeypox Virus Monoclonal Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Monkeypox Virus Monoclonal Antibody market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monkeypox Virus Monoclonal Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monkeypox Virus Monoclonal Antibody.

This report presents a comprehensive overview, market shares, and growth opportunities of Monkeypox Virus Monoclonal Antibody market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Purity>90%
    Purity>95%
    Others

Segmentation by Application:

    Diagnostic Laboratories
    Research and Academic Laboratories
    Pharmaceutical and Biotechnology Companies

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    ProteoGenix
    ACROBiosystems
    Creative Diagnostics
    Novus Biologicals, LLC
    Merck Group
    Absolute Antibody
    Creative Biolabs
    Sanyoubio
    Cnpair
    Vazyme
    Sinobiological

Key Questions Addressed in this Report

What is the 10-year outlook for the global Monkeypox Virus Monoclonal Antibody market?
What factors are driving Monkeypox Virus Monoclonal Antibody market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Monkeypox Virus Monoclonal Antibody market opportunities vary by end market size?
How does Monkeypox Virus Monoclonal Antibody break out by Type, by Application?